eLifeGenomicsPeer-reviewed journal article
Quantitative proteomics reveals key roles for post-transcriptional gene regulation in the molecular pathology of FSHD
Sujatha JagannathaniD, Yuko OgataiD, Philip R. GafkeniD, Stephen J. TapscottiD, Robert K. BradleyiD
Abstract
DUX4 is a transcription factor whose misexpression in skeletal muscle causes facioscapulohumeral muscular dystrophy (FSHD). While DUX4s transcriptional activity has been extensively characterized, the DUX4-induced proteome remains undescribed. Here, we report concurrent measurement of RNA and protein levels in DUX4-expressing cells via RNA-seq and quantitative mass spectrometry. DUX4 transcriptional targets were robustly translated, confirming the likely clinical relevance of proposed FSHD biomarkers. However, a multitude of mRNAs and proteins exhibited discordant expression changes upon DUX4 expression. Our dataset revealed unexpected proteomic, but not transcriptomic, dysregulation of diverse molecular pathways, including Golgi apparatus fragmentation, as well as extensive post-transcriptional buffering of stress response genes. Key components of RNA degradation machineries, including UPF1, UPF3B, and XRN1, exhibited suppressed protein, but not mRNA, levels, explaining the build-up of aberrant RNAs that characterizes DUX4-expressing cells. Our results provide a resource for the FSHD community and illustrate the importance of post-transcriptional processes to DUX4-induced pathology.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 63
- FWCI
- 1.82
- Field percentile
- top 15%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Relationship of DUX4 and target gene expression in FSHD myocytes
Jonathan Chau, Xiangduo Kong, … Kyoko Yokomori·Human MutationPeer-reviewed·Jan 27, 2021
- Posttranslational modifications of the DUX4 protein impact toxic function
Renatta N. Knox, Jocelyn O. Eidahl, … Scott Q. Harper·bioRxiv·Jul 22, 2022
- An in silico FSHD muscle fibre for modelling DUX4 dynamics and predicting the impact of therapy
M. V. Cowley, J. Pruller, … C. R. S. Banerji·bioRxiv·Dec 12, 2022
- Developmental regulators drive DUX4 expression in facioscapulohumeral muscular dystrophy
Amelia Fox, Jonathan Oliva, … Francis M. Sverdrup·bioRxiv·May 21, 2024
- P38α Regulates Expression of DUX4 in Facioscapulohumeral Muscular Dystrophy
Luis Alejandro Rojas, Erin Valentine, … Owen B. Wallace·Journal of Pharmacology and Experimental TherapeuticsPeer-reviewed·Jun 23, 2020
- Single-nucleus RNA-seq identifies divergent populations of FSHD2 myotube nuclei
Shan Jiang, Katherine Williams, … Ali Mortazavi·PLoS GeneticsPeer-reviewed·May 4, 2020